ArticleAge and ageing2017
Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry.
Article in Age and ageing, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05817188 (Translational Identification of Medication Repurposing Candidates to Slow Cognitive Decline in Dementia), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Translational Identification of Medication Repurposing Candidates to Slow Cognitive Decline in Dementia
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- Trends in First-Time Symptomatic Antidementia Drug Dispensations to Home-Dwelling People in Norway: A Nationwide Register-Based Study.Drugs - real world outcomes · 2026Article
- Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016).Journal of Alzheimer's disease : JAD · 2025Article
- Acute Kidney Injury and Its Association With Dementia and Specific Dementia Types: Findings From a Population-Based Study in Sweden.Neurology · 2024Article
- Immigration and access to dementia diagnostics and treatment: A nationwide study in Sweden.SSM - population health · 2024Article
- Is liquid biopsy mature enough for the diagnosis of Alzheimer's disease?Frontiers in aging neuroscience · 2022Review
- Article
- Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study.Journal of internal medicine · 2021Article
- Characteristics of patients assessed for cognitive decline in primary healthcare, compared to patients assessed in specialist healthcare.Scandinavian journal of primary health care · 2020Observational
- Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis.PloS one · 2020Article
- The caregiving phenomenon and caregiver participation in dementia.Scandinavian journal of caring sciences · 2019Review
- Basic Diagnostic Work-Up Is More Complete in Rural than in Urban Areas for Patients with Dementia: Results of a Swedish Dementia Registry Study.Journal of Alzheimer's disease : JAD · 2019Article
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.Nature reviews. Neurology · 2018Review
- Should frail older adults be in long-term care facilities?Journal of multidisciplinary healthcare · 2018Article
- Lay Knowledge About Dementia in Iceland: Symptoms and Risk and Protective Factors.Gerontology & geriatric medicineArticle
- Diagnosing dementia and cognitive dysfunction in the elderly in primary health care: A systematic review.Dementia & neuropsychologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: the increasing prevalence of Alzheimer's dementia (AD) has shifted the burden of management towards primary care (PC). Our aim is to compare diagnostic process and management of AD in PC and specialist care (SC). Design: cross-sectional study. Subjects: a total of, 9,625 patients diagnosed with AD registered 2011-14 in SveDem, the Swedish Dementia Registry. Methods: descriptive statistics are shown. Odds ratios are presented for test performance and treatment in PC compared to SC, adjusted for age, sex, Mini-Mental State Examination (MMSE) and number of medication. Results: a total of, 5,734 (60%) AD patients from SC and 3,891 (40%) from PC. In both, 64% of patients were women. PC patients were older (mean age 81 vs. 76; P < 0.001), had lower MMSE (median 21 vs. 22; P < 0.001) and more likely to receive home care (31% vs. 20%; P < 0.001) or day care (5% vs. 3%; P < 0.001). Fewer diagnostic tests were performed in PC and diagnostic time was shorter. Basic testing was less likely to be complete in PC. The greatest differences were found for neuroimaging (82% in PC vs. 98% in SC) and clock tests (84% vs. 93%). These differences remained statistically significant after adjusting for MMSE and demographic characteristics. PC patients received less antipsychotic medication and more anxiolytics and hypnotics, but there were no significant differences in use of cholinesterase inhibitors between PC and SC. Conclusion: primary and specialist AD patients differ in background characteristics, and this can influence diagnostic work-up and treatment. PC excels in restriction of antipsychotic use. Use of head CT and clock test in PC are areas for improvement in Sweden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.